Navigation Links
Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
Date:9/11/2007

., a Johnson & Johnson company, is a global medical device company that develops and markets surgical products for use in general surgery, wound management and women's health & urology. Johnson & Johnson Wound Management, a division of ETHICON, offers a complete portfolio of topical and advanced hemostatic products including SURGICEL* Absorbable Hemostat, SURGIFOAM* Absorbable Gelatin Sponge, EVICEL* Fibrin Sealant (Human), and SURGIFLO* Hemostatic Matrix with FlexTip. For more information about ETHICON, please visit http://www.ethicon.com .

*Trademark


'/>"/>
SOURCE ETHICON, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... BEND, Oregon, November 9 Bend...of experience in applying innovative pharmaceutica...fficult scientific and,technical problems, announc...with Vertex Pharmaceuticals Incorporated, a global... MA. , Through this new collaboration, Ve...
(Date:11/9/2009)... BOSTON, Nov. 9 PAREXEL ...ing global biopharmaceutical services provider, to...ety capabilities for early phase clinical developm...nc., which manufactures and distributes electrocar...wide. PAREXEL is using Mortara Instrument,s Survey...
(Date:11/9/2009)... HOPKINTON, Mass., Nov. 9 /PRNewswire-FirstCall/ -...leading provider of tools and services for drug di...d that its Caliper Discovery Alliances and Service...tment for $1.8 million under its contract with the...,s ToxCast screening program. This new task order...
Breaking Medicine Technology:Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5Caliper Awarded New Task Order for EPA ToxCast Program 2Caliper Awarded New Task Order for EPA ToxCast Program 3CyberKnife Center of Miami Executive Director James G Schwade M D Garners Ultimate Miami CEO Award 48158 1Gentiva 28R 29 Health Services to Present at Jefferies 3rd Annual Healthcare Conference 48155 1Gentiva 28R 29 Health Services to Present at Jefferies 3rd Annual Healthcare Conference 48155 2Gentiva 28R 29 Health Services to Present at Jefferies 3rd Annual Healthcare Conference 48155 3PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately 24125 Million 12517 1PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately 24125 Million 12517 2PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately 24125 Million 12517 3
...., Aug. 20 Do you currently have a study,that is ...ur sites,recruitment tools and a budget for media ...ps what you need is an extra set of hands to help,...and provide additional,administrative assistance a...M) service," says Ms. Ann Kottcamp,President of Ar...
... Aug. 19 Addrenex Pharmaceuticals (, http://www.a... month to,further its goal of identifying and deve...r the next 18 months., The fast-paced timeline th...,s recent successes in developing two new drugs, C...order and CloniBID for hypertension,over the past ...
Other Medicine Technology:Argonauta Assist(TM)ance: Argonauta Communications Strives to Enhance Site-Based Recruitment Efforts 2Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 2Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 3
(Date:11/9/2009)...tCall/ - Hard To Treat Diseases (HTDS.PK) www.htd...$41 billion international healthcare company, is a...r, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.,...begin a five-year, $1 billion China initiative wit... its investment in its China R&D facility, and...
(Date:11/9/2009)...late when it comes to preventing or improving a di...ke Off Pounds Sensibly), the nonprofit weight-loss...(Vocus) November 9, 2009 -- Tomorrow may be too la...etes condition, according to TOPS Club, Inc. (Take...upport organization., , ,Diabetes is a disease in ...
(Date:11/9/2009)... positive influence of sports participation on bon...Vocus) November 9, 2009 -- As people age fractures...ch has highlighted the importance of exercise and ...However, a new study published in the November/Dec... Approach reveals that there may be significant g...
(Date:11/9/2009).../ -- Actress Mariska Hargitay and the Joyful Hea...to raise awareness about the need for domestic vio...ilding healing and wellness kits for women in cris... to each of the estimated 600 women currently bein...iolence shelters. ,, "Our goal is to shine a li...
(Date:11/9/2009)...assador ,, WHITE PLAINS, N.Y., Nov. 9 /PRNews..., was born so early and with so many underdevelope...ld survive -- or if he would ever walk, talk, see ...Dimes 2010 National Ambassador. ,, Joshua,s mo...motherhood and I was completely devastated. My hus...
Breaking Medicine News(10 mins):Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3
...rs tend to prescribe unwanted, even possibly harmf...rs in the name of lecture assignments. Lawma...uire drug makers to disclose payments made to doct... specialty. Not coincidentally prescription o...
...ent. It hopes after the ban on smoking in public p... smokers in the country would come down dramatical...campaigners are not so sure. "The affluent in...rnott, director of Action on Smoking and Health (A...
...e is desperate to perform with, it would be Britis...ists that Coldplay are the 'modern Beatles', and t...ith them. And, even in the band Timberlake...hem - especially Chris Martin," The Sun quoted him...
...e been deployed worldwide to provide early detecti...t attacks. New methods that improve the over...ve a broad practical impact. However, most surveil...the Olympic Games. In this modeling paper ...
...of York and Hull York Medical School has confirmed...e. Folate is a vitamin that comes from ve...beans and peas. Fortified cereal products, sunflow... of babies with disabilities such as spina bifida,...
...shington shows that the work intended for global h...onomy . The research was conducted by a UW ...phy; Amy Hagopian, professor in the School of Publ...director of the Department of Global Health. The...
Other Medicine News:Health News:US Lawmakers Considering Legislation to Restrict Payments by Drug Companies to Doctors 2Health News:US Lawmakers Considering Legislation to Restrict Payments by Drug Companies to Doctors 3Health News:Ban on Smoking is Not a Magic Wand to Reduce Health Inequalities, UK Campaigners Warn 2Health News:Ban on Smoking is Not a Magic Wand to Reduce Health Inequalities, UK Campaigners Warn 3Health News:Global Health Enriching the States Economy 2
XKnife
Primus Linear Accelerator
Clinac 21EX Platinum
...en and reliable system. Varian accelerators offers...astest beam-on times to full stability and flatnes...m control for dynamic treatments, highest beam sta...LC) products that achieve the finest dose contouri...
Medicine Products: